🇺🇸 FDA

Drug profile · INN

mycobacterium tuberculosis derived antigens (rdesat-6 / rcfp-10)

SIILTIBCY

EMA: approved V04CF
Patents linked
0
News articles
0

Quick answer

mycobacterium tuberculosis derived antigens (rdesat-6 / rcfp-10) (SIILTIBCY) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN mycobacterium tuberculosis derived antigens (rdesat-6 / rcfp-10)
Brand SIILTIBCY
ATC code V04CF

Frequently asked questions

What is mycobacterium tuberculosis derived antigens (rdesat-6 / rcfp-10)?

mycobacterium tuberculosis derived antigens (rdesat-6 / rcfp-10) (SIILTIBCY) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for mycobacterium tuberculosis derived antigens (rdesat-6 / rcfp-10)?

SIILTIBCY is a marketed brand name for mycobacterium tuberculosis derived antigens (rdesat-6 / rcfp-10). Check FDA Drugs@FDA for the current US label holder and prescribing information.